Patent · US Active

Modulating the alternative complement pathway

US10233235B2 · kind B2 · utility

1Cited by
6References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 15, 2014
Grant dateMar 19, 2019
Priority date
Expiry dateDec 12, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y402/01002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions, including pharmaceutical compositions, and methods for modulating, i.e., stimulating or inhibiting, activity of the alternative complement pathway, and methods of identifying factor H-binding proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.